Trials / Conditions / Primary Sjogren's Syndrome

Primary Sjogren's Syndrome

9 registered clinical trials studyying Primary Sjogren's Syndrome — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's S NCT06967038	Bangdong Gong	Phase 1 / Phase 2
Withdrawn	Anti-BTLA Agonist Therapy in Subjects With Primary Sjogren's Syndrome NCT05781451	Stanford University	Phase 2
Completed	A Study to Evaluate the Efficacy and Safety of Telitacicept in Subjects With Active Primary Sjogren's Syndrome NCT05673993	RemeGen Co., Ltd.	Phase 3
Withdrawn	BAFF/IL-17 Bispecific Antibody Treatment in Subjects With Primary Sjogren's Syndrome NCT04563195	Matthew C. Baker	Phase 2 / Phase 3
Unknown	Clinical Study of Jianfei Kangfu Cao in the Treatment of pSS-ILD NCT04544722	Shanghai University of Traditional Chinese Medicine	N/A
Withdrawn	Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II NCT02027298	The Cleveland Clinic	Phase 2
Unknown	Exercise in Sjogren, Myositis and Takayasu's Arteritis NCT01501019	University of Sao Paulo	N/A
Unknown	Confocal Microscopy and Lacrimal Gland in Sjogren's Syndrome NCT00920179	Keio University	—
Completed	Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome NCT00542763	University Hospital Muenster	Phase 1